“The usefulness of serum beta-2 microglobulin as a biomarker for evaluating renal function decline in type II diabetes mellitus”, Baghdad J. Biochem. Appl. Biol. Sci., vol. 3, no. 01, pp. 51–59, Mar. 2022, doi: 10.47419/bjbabs.v3i01.40.